Zelira in the news
For media related enquiries please contact Damien Carbon at Profile Media
Ph: +61 (0) 412 332 122 E: email@example.com
VIRIATHUS RESEARCH REPORT
Zelda Therapeutics is developing and hopes to soon license medicinal cannabis formulations that treat common medical disorders. The Company has clinical trials underway in autism and insomnia and pre-clinical research rograms progressing in cancers of the breast, pancreas and brain and in diabetes-related cognitive decline.